Filter By:
340B In The News
“GAO: Feds have to improve oversight to stop drug companies from doling out duplicate 340B, Medicaid discounts”
January 28, 2020
Press Releases
IN CASE YOU MISSED IT: New Study Finds Hospitals Charge Nearly Two Times More Than Physician Offices for Same Cancer Treatments
New research from the Employee Benefit Research Institute (EBRI) has concluded that payments from private third-party payers for infused cancer medicines are, on average, twice as much when care is provided in hospital outpatient departments (HOPDs) compared with physician offices (POs).
January 22, 2020
Press Releases
IN CASE YOU MISSED IT: New GAO Report Finds Oversight Lacking For 340B Hospitals
A new report from the Government Accountability Office (GAO) has concluded increased oversight is needed to ensure nongovernmental hospitals meet 340B eligibility requirements.
January 15, 2020
340B In The News
“Pharmacy middlemen benefit from drug discount program intended to help poor Ohioans”
January 13, 2020
340B In The News
“Government watchdog finds lax oversight of 340B discounts”
January 13, 2020
340B In The News
“Community Oncology Clinics Continue to Suffer Due to 340B Drug Discount Program”
January 3, 2020
340B In The News
“Put Vulnerable Patients Before Profit”
December 31, 2019
340B In The News
“Let’s Keep Bad Players from Ruining a Good Program”
November 21, 2019